Amicus Therapeutics (FOLD) Tops Q4 EPS by 8c

Amicus Therapeutics (NASDAQ: FOLD) reported Q4 EPS of $0.09, $0.08 better than the analyst estimate of $0.01.

For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• Alphabet to replace Verizon in the Dow Jones Industrial Average